The Central Drugs Standard Control Organisation (CDSCO) released its September report. It found that 49 out of 3,000 tested pharmaceutical products failed quality standards. This includes Calcium 500 mg and Vitamin D3 tablets from Life Max Cancer Laboratories.
The CDSCO flagged four medicines made by counterfeit companies as spurious. It recalled these non-compliant drugs in batches to ensure public safety.
CDSCO Chief Rajeev Singh Raghuvanshi reported that only about 1% of tested drugs did not meet quality benchmarks. This low percentage shows that strict monitoring effectively controls substandard drug production.
The report highlighted several other products with quality issues, including:
It also mentioned a Gauze Roll Non-Sterile Roller Bandage and Diclofenac Sodium tablets among the failed products.
The CDSCO conducts this monthly review to reduce the number of non-standard quality (NSQ) drugs in the market.
